Daiichi’s $150M build in China; BioMarin reveals €60M Irish expansionnews2024-12-12T15:38:48+00:00December 12th, 2024|Endpoints News|
Lonza looks to depart capsule and health ingredients as it undergoes restructurenews2024-12-12T11:28:49+00:00December 12th, 2024|Endpoints News|
Biosecure bill is left out of end-of-year defense packagenews2024-12-08T02:00:38+00:00December 8th, 2024|Endpoints News|
European Commission greenlights $16.5B Novo-Catalent acquisition news2024-12-06T18:32:53+00:00December 6th, 2024|Endpoints News|
National Resilience to cut 105 employees at Florida site as new CEO takes overnews2024-12-06T16:16:09+00:00December 6th, 2024|Endpoints News|
UK’s local vaccine production stymied by budget cuts, government committee saysnews2024-12-06T12:30:04+00:00December 6th, 2024|Endpoints News|
Lilly continues to expand its empire of GLP-1 factories with new $3B buildoutnews2024-12-05T20:30:57+00:00December 5th, 2024|Endpoints News|
Biosecure compromise could add review process for named companies, sources saynews2024-12-05T19:18:15+00:00December 5th, 2024|Endpoints News|
Amgen deepens roots in North Carolina with latest $1B factory build news2024-12-05T17:01:34+00:00December 5th, 2024|Endpoints News|
National Resilience’s new CEO; Moderna opens Australian manufacturing sitenews2024-12-05T16:26:22+00:00December 5th, 2024|Endpoints News|
